Mitre Medical

Mitre_Medical_LOGO_HI-REZ

Mitre Medical gears up to treat heart disease patients in US-based study of its Mitral Touch device

Mitre Medical Corp CEO John MacMahon tells Proactive the privately-held group is developing a less invasive and safer approach to treat functional mitral valve regurgitation (MR) in patients with moderate to severe MR. MacMahon says the group recently announced one-year results of the group’s Mitral Touch in European patients, and looks forward to bringing the technology … Read more

Mitre Medical Corp. Announces the Publication of One-Year Results of the Mitral Touch in the Journal of Thoracic and Cardiovascular Surgery

Journal of Thoracic and Cardiovascular Surgery

Results Set the Stage for an Upcoming US Trial January 6, 2021 – Morgan Hill, CA – Mitre Medical Corp., (“Mitre” or “company”) an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional/secondary mitral valve regurgitation (FMR) and remodel the left ventricle (LV), announced the publication of … Read more

Mitre Medical Corp. Strengthens Global Marketing Team with the Appointment of MedMarket Access, LLC

September 10, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV).  Mitre has appointed MedMarket Access, LLC (“MedMarket Access”) to support the company’s … Read more

Mitre Medical Corp. Retains Zimmons International Communications, Inc. for Investor Relations Activities

August 27, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre Medical” or “company”), an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR, has retained Zimmons International Communications, Inc. … Read more

Mitre Medical Receives FDA Approval For the ENRAPT-US Early Feasibility Study

The Mitral Touch Empowers Surgeons to Treat Functional MR on a Beating Heart Mitre Medical is pleased to announce concurrent to the PCR-London Valves Conference that the FDA has determined Mitre Medical Corp. has provided sufficient data to support initiation of a human clinical study to evaluate the safety and performance of the Mitral Touch … Read more

Structural Heart Treatment Meets Structural Heart Imaging: Mitre Medical Announces Partnership with Laralab

New AI-based CT Imaging Helps Screen and Assess Patients for the Mitral Touch Epicardial Clip Mitre Medical Corp. and Laralab UG have partnered to provide surgeons with the most advanced 3D epicardial models ever made prior to surgery. This software has also provided the assessment of the Mitral Touch’s performance in heart failure patients in … Read more

Minimally Invasive Delivery of the Mitral Touch and 1-Year Follow-Up of the ENRAPT-MR Study will be Presented at EACTS 2019 Techno College

The Mitral Touch Represents a Breakthrough in the Surgical Treatment of Heart Failure The Mitral Touch is an epicardial clip designed to reduce mitral regurgitation and provide subvalvular support of the left ventricle for functional mitral regurgitation (FMR) patients. The ENRAPT-MR study investigated the safety and performance of the Mitral Touch during concomitant treatment of … Read more

Nancy Briefs Joins Mitre Medical Corp. Board of Directors

Nancy Briefs Joins Mitre Medical Corp. Board of Directors Morgan Hill, CA.  Mitre Medical is pleased to announce the addition of Nancy Briefs to our Board of Directors.  Ms. Briefs is a strategic business leader in life sciences, with extensive experience creating value, driving strategy, and launching products. In her career, Ms. Briefs has raised over … Read more

Mitre Medical Corp. to Present a Beating Heart Option for Functional MR Repair and Will Present 6-Month Results from the ENRAPT-MR Trial at Two Upcoming European Cardiac Surgery Conferences.

Silicon Valley, September 7, 2018 –Mitre Medical has been invited to introduce the Mitral Touch epicardial annuloplasty system that enables a beating heart option for the surgical treatment of mitral regurgitation during the 9 September Innovator’s Day poster session, as part of the PCR London Valves meeting, to be held 9–11 September in London, UK.  … Read more

AngioConsult strengthens the cooperation with Mitre Medical Corp. with the addition of Andrew Kim to the team.

Speyer/Silicon Valley, 05/08/2018 – AngioConsult announces the strengthening of the cooperation with Mitre Medical Corp. with the addition of Andrew Kim to the team. Andrew is the second representative of AngioConsult supporting the medical device company, which is based in Silicon Valley, California. Benjamin Rieck, Sr Managing Partner of the healthcare consultancy with headquarters in … Read more